Understanding how endogenous and pharmacological incretin pathways interact, across neural circuits, metabolic organs, and sex-specific contexts, will be crucial to developing the next generation of personalized anti-obesity and antidiabetic therapies. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.